| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus (NCT01627340) | GlaxoSmithKline | 2012-07-24 |
| A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium (NCT01691482) | GlaxoSmithKline | 2012-07-23 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults (NCT01626820) | GlaxoSmithKline | 2012-07-19 |
| Investigation of Topical SB705498 on Healthy Volunteers (NCT01673529) | GlaxoSmithKline | 2012-07-17 |
| Belimumab (BENLYSTA®) Pregnancy Registry (NCT01532310) | GlaxoSmithKline | 2012-07-16 |
| Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A (NCT01610414) | GlaxoSmithKline | 2012-07-13 |
| Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants (NCT01616459) | GlaxoSmithKline | 2012-07-11 |
| A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above (NCT01607112) | GlaxoSmithKline | 2012-07-10 |
| An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode (NCT01653509) | GlaxoSmithKline | 2012-07-01 |
| Special Drug Use Investigation for ROTARIX® (NCT01636739) | GlaxoSmithKline | 2012-07-01 |
| Effects of Salmeterol on Autonomic Nervous System (NCT01536587) | GlaxoSmithKline | 2012-07-01 |
| Influenza Burden Assessment in the United States, July1997 - up to April 2009 (NCT01599390) | GlaxoSmithKline | 2012-07-01 |
| Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients (NCT01636778) | GlaxoSmithKline | 2012-07-01 |
| WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes (NCT01681979) | GlaxoSmithKline | 2012-07-01 |
| BE STUDY OF METFORMIN GSK 1000mg (NCT01710553) | GlaxoSmithKline | 2012-07-01 |
| WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects (NCT01763463) | GlaxoSmithKline | 2012-07-01 |
| A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD (NCT01636713) | GlaxoSmithKline | 2012-07-01 |
| A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy (NCT01610492) | GlaxoSmithKline | 2012-07-01 |
| A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (NCT01602549) | GlaxoSmithKline | 2012-07-01 |
| Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (NCT01673490) | GlaxoSmithKline | 2012-06-29 |
| Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects (NCT01610427) | GlaxoSmithKline | 2012-06-25 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age (NCT01621802) | GlaxoSmithKline | 2012-06-21 |
| Pertussis Infection in Adolescents and Adults With Prolonged Cough (NCT01597687) | GlaxoSmithKline | 2012-06-20 |
| BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 (NCT01597622) | GlaxoSmithKline | 2012-06-11 |
| Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses (NCT01615796) | GlaxoSmithKline | 2012-06-04 |
| Drug Use Investigation for ROTARIX® (NCT01636193) | GlaxoSmithKline | 2012-06-01 |
| Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis (NCT01630135) | GlaxoSmithKline | 2012-06-01 |
| Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis (NCT01622231) | GlaxoSmithKline | 2012-06-01 |
| Pharmacokinetic Study of 4 mg Nicotine Lozenge. (NCT01669122) | GlaxoSmithKline | 2012-06-01 |
| Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study (NCT01418937) | GlaxoSmithKline | 2012-05-29 |
| 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease (NCT01587924) | GlaxoSmithKline | 2012-05-23 |
| Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea (NCT01568060) | GlaxoSmithKline | 2012-05-21 |
| Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children (NCT01545375) | GlaxoSmithKline | 2012-05-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235. (NCT01607385) | GlaxoSmithKline | 2012-05-18 |
| 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis (NCT01587898) | GlaxoSmithKline | 2012-05-17 |
| Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers (NCT01673555) | GlaxoSmithKline | 2012-05-15 |
| A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors (NCT01582997) | GlaxoSmithKline | 2012-05-11 |
| BE Study of Metformin GSK 500mg (NCT01710527) | GlaxoSmithKline | 2012-05-09 |
| Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients (NCT01602562) | GlaxoSmithKline | 2012-05-07 |
| Pharmacokinetic Study of Levocetirizine Oral Solution (NCT01622283) | GlaxoSmithKline | 2012-05-02 |
| A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom (NCT01292213) | GlaxoSmithKline | 2012-05-01 |
| Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus (NCT01584843) | GlaxoSmithKline | 2012-05-01 |
| WEUSKOP6166: Lamotrigine and Aseptic Meningitis (NCT01657864) | GlaxoSmithKline | 2012-05-01 |
| Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice (NCT01657877) | GlaxoSmithKline | 2012-05-01 |
| ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease (NCT01607398) | GlaxoSmithKline | 2012-05-01 |
| A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma (NCT01641692) | GlaxoSmithKline | 2012-05-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender (NCT01687309) | GlaxoSmithKline | 2012-04-30 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. (NCT01587716) | GlaxoSmithKline | 2012-04-23 |
| Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine (NCT01353703) | GlaxoSmithKline | 2012-04-16 |
| Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites (NCT01956487) | GlaxoSmithKline | 2012-04-11 |
| Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects (NCT01462669) | GlaxoSmithKline | 2012-04-10 |
| A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723 (NCT01602601) | GlaxoSmithKline | 2012-04-09 |
| Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma (NCT01573624) | GlaxoSmithKline | 2012-04-03 |
| A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease (NCT01494532) | GlaxoSmithKline | 2012-04-02 |
| A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies (NCT01607372) | GlaxoSmithKline | 2012-04-01 |
| A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia (NCT01563055) | GlaxoSmithKline | 2012-04-01 |
| Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension (NCT01858831) | GlaxoSmithKline | 2012-04-01 |
| Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children (NCT01573767) | GlaxoSmithKline | 2012-04-01 |
| Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity (NCT01592851) | GlaxoSmithKline | 2012-04-01 |
| WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) (NCT01616472) | GlaxoSmithKline | 2012-04-01 |
| Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease (NCT01627327) | GlaxoSmithKline | 2012-04-01 |
| Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population (NCT01755637) | GlaxoSmithKline | 2012-04-01 |
| Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics (NCT01563081) | GlaxoSmithKline | 2012-04-01 |
| Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment (NCT01571999) | GlaxoSmithKline | 2012-03-29 |
| A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers (NCT01587703) | GlaxoSmithKline | 2012-03-28 |
| A Dose-ranging Study of Fluticasone Furoate (FF) (NCT01563029) | GlaxoSmithKline | 2012-03-28 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057 (NCT01587807) | GlaxoSmithKline | 2012-03-28 |
| Ability of Four Toothpastes to Remove Plaque (NCT03285984) | GlaxoSmithKline | 2012-03-27 |
| A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD) (NCT01551758) | GlaxoSmithKline | 2012-03-13 |
| Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules (NCT01562444) | GlaxoSmithKline | 2012-03-08 |
| A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers (NCT01577680) | GlaxoSmithKline | 2012-03-05 |
| Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain (NCT01521286) | GlaxoSmithKline | 2012-03-01 |
| WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction (NCT01636726) | GlaxoSmithKline | 2012-03-01 |
| The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity (NCT03072719) | GlaxoSmithKline | 2012-03-01 |
| Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. (NCT01520909) | GlaxoSmithKline | 2012-03-01 |
| Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) (NCT01428544) | GlaxoSmithKline | 2012-03-01 |
| A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers (NCT01702519) | GlaxoSmithKline | 2012-03-01 |
| The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity (NCT01592864) | GlaxoSmithKline | 2012-03-01 |
| Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions (NCT01641237) | GlaxoSmithKline | 2012-03-01 |
| A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects (NCT01648179) | GlaxoSmithKline | 2012-03-01 |
| A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris (NCT01527123) | GlaxoSmithKline | 2012-02-28 |
| A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers (NCT01563042) | GlaxoSmithKline | 2012-02-13 |
| Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children (NCT01506193) | GlaxoSmithKline | 2012-02-06 |
| Exploratory Efficacy Study of Guaifenesin in Upper Back Pain (NCT01562548) | GlaxoSmithKline | 2012-02-01 |
| A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD (NCT01516437) | GlaxoSmithKline | 2012-02-01 |
| GW824575 First Time in Human (NCT01551771) | GlaxoSmithKline | 2012-02-01 |
| Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics (NCT01822665) | GlaxoSmithKline | 2012-02-01 |
| A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema (NCT01506895) | GlaxoSmithKline | 2012-02-01 |
| Patch Test of Benzalkonium Chloride Disinfectant Spray (NCT01762982) | GlaxoSmithKline | 2012-02-01 |
| Rechallenge, Potential Drug Induced Liver Injury (Kaiser) (NCT01584765) | GlaxoSmithKline | 2012-02-01 |
| A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model (NCT01607411) | GlaxoSmithKline | 2012-02-01 |
| A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease (NCT01485172) | GlaxoSmithKline | 2012-01-31 |
| Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers (NCT01561976) | GlaxoSmithKline | 2012-01-30 |
| Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers (NCT01340898) | GlaxoSmithKline | 2012-01-27 |
| A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol (NCT01540708) | GlaxoSmithKline | 2012-01-16 |
| An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed (NCT01583036) | GlaxoSmithKline | 2012-01-16 |
| Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. (NCT01597700) | GlaxoSmithKline | 2012-01-13 |
| Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers (NCT01536678) | GlaxoSmithKline | 2012-01-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry (NCT01498653) | GlaxoSmithKline | 2012-01-01 |
| A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise (NCT01435902) | GlaxoSmithKline | 2012-01-01 |